Axsome Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options.
2024/3/18 18:00:34
(AXSM:NASDAQ)
Newsletter coverage
Streetwise Reports Articles